Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Clonidine for Night Sweats Management

Introduction to Clonidine Therapy

  • The American Academy of Sleep Medicine suggests that for night sweats specifically, doses of 0.1-0.2 mg at bedtime have shown efficacy 1
  • Clonidine, an α2-adrenergic receptor agonist, suppresses sympathetic nervous system outflow throughout the brain, which may contribute to its effects on night sweats 2, 4

Efficacy and Dosage

  • Clonidine has shown mild to moderate efficacy in treating menopausal hot flashes, reducing them by up to 46% 1
  • For PTSD-associated nightmares, doses of 0.2-0.6 mg daily (in divided doses) have been effective 2, 3
  • A 2-week pilot study found that 0.1 mg clonidine twice daily decreased the frequency of nightmares in patients with PTSD 4, 5

Monitoring and Side Effects

  • The American College of Cardiology recommends monitoring for orthostatic hypotension, especially when increasing doses, and avoiding abrupt discontinuation to prevent hypertensive crisis 2, 3, 6
  • Common side effects include dry mouth and insomnia or drowsiness 1
  • Doses used specifically for treating hot flashes generally do not significantly affect blood pressure 1

Special Considerations and Alternative Options

  • For PTSD-related night sweats, prazosin (an alpha-1 blocker) is considered first-line with stronger evidence (Level A recommendation) compared to clonidine (Level C recommendation) 2, 3
  • If clonidine is ineffective or poorly tolerated, consider alternative options like prazosin, SSRI/SNRIs, or gabapentin, particularly for menopausal hot flashes or hot flashes in breast cancer patients 1, 2, 3

REFERENCES